A multicenter phase II trial of S-1 combined with bevacizumab after platinum-based chemotherapy in patients with advanced non-squamous non-small cell lung cancer
Crossref DOI link: https://doi.org/10.1007/s00280-016-3101-z
Published Online: 2016-07-11
Published Print: 2016-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yamada, Kazuhiko
Ichiki, Masao
Takahashi, Kazuhisa
Hisamatsu, Yasushi
Takeoka, Hiroaki
Azuma, Koichi
Shukuya, Takehito
Nishikawa, Kazuo
Tokito, Takaaki
Ishii, Hidenobu
Hoshino, Tomoaki
License valid from 2016-07-11